Dihexa.
An advanced cognitive peptide for synapse formation and memory — provider-directed only.
Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Patients wanting advanced cognitive enhancement
- Patients experiencing memory or processing decline
- Patients under close provider supervision
This isn't for you if
Used conservatively. Patients with neurologic, psychiatric, or seizure history require specialist clearance. Not appropriate during pregnancy or with active malignancy.
Dihexa
Dihexa is an advanced cognitive peptide that supports synapse formation and brain-derived growth pathways associated with cognition and memory. It is reserved for select, provider-directed cases.
Mechanism and fit.
Dihexa enhances neuroplasticity by supporting synapse formation and growth-factor signaling in the brain. It is considered a higher-level cognitive optimization peptide and is dosed conservatively and selectively.
Who this is typically for.
- Patients wanting advanced cognitive enhancement
- Patients experiencing memory or processing decline
- Patients under close provider supervision
What patients
most often ask.
Why is Dihexa used cautiously?
Dihexa is a high-potency cognitive peptide with limited human data. It is reserved for short, provider-directed cycles in select patients.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Patients wanting advanced cognitive enhancement</li><li>Patients experiencing memory or processing decline</li><li>Patients under close provider supervision</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingLow-dose, provider-directed.
- Typical durationShort cycles, typically 4–6 weeks.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering Dihexa, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.